PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine and Cardiology, Charité University Medicine, Berlin, Germany.\', \'Institut für Physiologie und Pathophysiologie, Paracelsus Medizinische Privatuniversität, Nürnberg, Germany.\', \'German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany.\', \'Berlin Institute of Health (BIH) at Charité Universitätsmedizin Berlin, Stem Cell Core, Berlin, Germany.\', \'Imperial College London, Hammersmith Hospital, London, England, United Kingdom.\', \'Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Berlin, Germany.\', \'Department of Hematology, Oncology and Tumorimmunology, Charité University Medicine, Berlin, Germany.\', \'Department of Internal Medicine and Cardiology, German Heart Center Berlin, Berlin, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1371/journal.pone.0255976
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 34411149
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
is ?:relation_isRelatedTo_publication of
?:title
  • COVID19-associated cardiomyocyte dysfunction, arrhythmias and the effect of Canakinumab.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all